查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1813576

全球TIL疗法市场分析与预测（至2034年）：类型、产品、服务、技术、应用、最终用户、流程、阶段与解决方案

TIL Therapy Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Process, Stage, Solutions
出版日期: | 出版商: Global Insight Services | 英文 324 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球TIL疗法市场预计将从2024年的4亿美元增加到2034年的61亿美元，复合年增长率约为31.3%。 TIL疗法市场涉及利用肿瘤浸润淋巴细胞(TIL)的治疗。 TIL是从患者肿瘤中提取的免疫细胞，在试管内扩增，然后重新输注用于靶向癌细胞。这种个人化免疫疗法旨在增强人体自身的抗肿瘤反应。癌症盛行率的上升和细胞治疗技术的进步正在推动市场成长，其重点是提高疗效、降低成本和扩大临床应用。

在个人化癌症治疗方法的推动下，TIL 疗法市场正在强劲扩张。黑色素瘤细分市场由于其对 TIL 疗法的高反应性和广泛的研究支持而处于领先地位。非小细胞肺癌 (NSCLC) 表现第二好，受益于越来越多的临床试验和令人鼓舞的初步结果。在黑色素瘤细分市场中，早期治疗显示出良好的前景，可改善患者的预后和存活率。在成功案例不断增加的推动下，晚期治疗也越来越受到关注。在 NSCLC 细分市场中，标靶治疗的进步使具有特定基因标记的患者成为主要受益者。专注于改进 TIL 收集技术和增强细胞扩增过程的研发投资对于推动市场向前发展至关重要。随着监管格局的发展，简化的核准途径预计将加速市场成长，促进创新并扩大治疗选择。

市场区隔
类型 自体TIL治疗、异体TIL治疗
产品 细胞培养基、试剂和试剂套件、设备和软体
服务 製造、品管、咨询、物流
科技 基因工程、细胞培养、冷冻保存、生物反应器
目的 肿瘤学、血液学、固态肿瘤、罕见疾病
最终用户 医院、专科诊所、研究机构、生物製药公司
流程 分离、扩增、活化、注入
阶段 临床前、临床、商业化
解决方案 承包、客製化和整合解决方案

市场概述

TIL 疗法市场正经历动态的格局，其特点是市场份额和策略性定价模式不断演变。免疫疗法技术的进步透过新产品的推出为市场注入了活力。各公司正专注于改善患者预后的创新疗法。这种竞争环境鼓励各公司透过独特的产品和策略联盟来实现差异化。定价策略越来越受到基于价值的模型的影响，这种模型的驱动力是强调成本效益和以患者为中心的护理。 TIL 疗法市场的竞争格局的特点是主要企业之间的激烈竞争。各公司正在利用技术创新和策略伙伴关係关係，同时进行基准化分析以保持竞争优势。法律规范显着影响市场动态，严格的指导方针决定产品开发和核准流程。北美和欧洲的监管格局尤其具有影响力，决定了市场进入和扩大策略。随着市场的发展，法规遵循和策略敏捷性对于持续成长和竞争优势仍然至关重要。

主要趋势和驱动因素：

在个人化医疗和免疫疗法的推动下，TIL 疗法市场正经历强劲成长。这些疗法因其能够靶向特定癌细胞并最大程度减少对健康组织的损害而受到青睐。研究人员正致力于利用基因工程和联合治疗来增强 TIL 疗法的疗效。此外，对生物技术和癌症研究的不断增加的投资也推动了市场扩张。政府和私人组织正在资助开发创新癌症疗法的计画。这些资金支持正在加速临床试验和监管核准，从而推动市场动态。全球癌症发生率的上升也是一个主要的市场驱动力。由于 TIL 疗法具有良好的临床效果，越来越多的患者和医疗保健提供者开始采用该疗法。精准医疗的趋势进一步推动了市场成长。此外，在医疗基础设施不断改善的发展中地区，发展机会也随之出现。投资于研发和策略合作伙伴关係的公司完全有能力抢占市场份额。随着对有效癌症治疗的需求不断增加，预计未来 TIL 疗法市场将继续扩大。

限制与挑战：

TIL 疗法市场面临着几个重大的限制和挑战。一个关键的挑战是高昂的製造和开发成本。这种经济负担限制了可近性和可扩展性，尤其是在新兴市场。此外，监管障碍和冗长的核准流程会减缓新治疗方法的推出，阻碍创新和市场渗透。另一个担忧是 TIL 疗法的复杂物流，需要专门的设施和熟练的人员。这种复杂性会增加​​营运成本并限制广泛采用。此外，缺乏支持 TIL 疗法长期疗效和安全性的全面临床数据可能会阻碍投资和患者的接受度。市场也面临来自 CAR-T 和查核点抑制剂等替代免疫疗法的激烈竞争，这些疗法可能会使 TIL 疗法黯然失色。最后，临床试验的患者招募仍然是一个挑战，严格的合格标准往往会影响研究倡议的速度和成功。

主要企业

Iovance Biotherapeutics、Adaptimmune Therapeutics、Kite Pharma、Immunocore、Turnstone Biologics、Tmunity Therapeutics、Cellectis、Autolus Therapeutics、Fate Therapeutics、Atara Biotherapeutics、Neogene Therapeutics、Instil Bio、Marker Therapeutics、ZGology、ZOologys Onpology、Zharmcology）

目录

第 1 章 TIL 治疗市场概述

  • 调查目的
  • TIL 疗法市场定义和研究范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章：重要考察

第四章 TIL 治疗市场展望

  • TIL疗法市场细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第 5 章 TIL 疗法的市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析
  • 近期动态

第六章 TIL疗法的市场规模

  • TIL 治疗市场规模（按价值）
  • TIL 治疗市场规模

第七章 TIL 疗法市场规模（按类型）

  • 市场概况
  • 自体TIL疗法
  • 异基因TIL治疗
  • 其他的

第 8 章 TIL 疗法市场：按产品

  • 市场概况
  • 细胞培养基
  • 试剂和套件
  • 装置
  • 软体
  • 其他的

9. TIL 治疗市场（按服务）

  • 市场概况
  • 製造业
  • 品管
  • 咨询
  • 后勤
  • 其他的

第 10 章 TIL 疗法市场：依技术分类

  • 市场概况
  • 基因工程
  • 细胞培养
  • 冷冻保存
  • 生物反应器
  • 其他的

第 11 章 TIL 治疗市场：按应用

  • 市场概况
  • 肿瘤学
  • 血液学
  • 固态肿瘤
  • 罕见疾病
  • 其他的

第 12 章 TIL 疗法市场（按最终用户划分）

  • 市场概况
  • 医院
  • 专科诊所
  • 研究所
  • 生物製药公司
  • 其他的

第十三章 TIL 疗法市场（按流程）

  • 市场概况
  • 隔离
  • 扩张
  • 启用设定
  • 注射
  • 其他的

第 14 章 TIL 疗法市场（按阶段）

  • 市场概况
  • 临床前
  • 临床
  • 商业的
  • 其他的

第 15 章 TIL 治疗市场（按解决方案）

  • 市场概况
  • 承包解决方案
  • 客製化解决方案
  • 整合解决方案
  • 其他的

第 16 章 TIL 疗法市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十七章竞争格局

  • 概述
  • 市占率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十八章：公司简介

  • Iovance Biotherapeutics
  • Adaptimmune Therapeutics
  • Kite Pharma
  • Immunocore
  • Turnstone Biologics
  • Tmunity Therapeutics
  • Cellectis
  • Autolus Therapeutics
  • Fate Therapeutics
  • Atara Biotherapeutics
  • Neogene Therapeutics
  • Instil Bio
  • Marker Therapeutics
  • Gritstone Oncology
  • Ziopharm Oncology
简介目录
Product Code: GIS34347

TIL Therapy Market is anticipated to expand from $0.4 billion in 2024 to $6.1 billion by 2034, growing at a CAGR of approximately 31.3%. The TIL Therapy Market encompasses treatments utilizing tumor-infiltrating lymphocytes, which are immune cells extracted from a patient's tumor, expanded in vitro, and reinfused to target cancer cells. This personalized immunotherapy aims to enhance the body's natural anti-tumor response. Increasing cancer prevalence and advancements in cell therapy technologies are propelling market growth, with a focus on improving efficacy, reducing costs, and expanding clinical applications.

The TIL Therapy Market is experiencing robust expansion, driven by advancements in personalized cancer treatment approaches. The melanoma segment leads in performance, owing to its higher responsiveness to TIL therapy and extensive research backing. Non-small cell lung cancer (NSCLC) follows as the second-highest performing segment, benefiting from increasing clinical trials and promising preliminary results. Within the melanoma sub-segment, early-stage interventions are showing significant promise, enhancing patient outcomes and survival rates. Advanced-stage treatments are also gaining traction, driven by a growing body of successful case studies. In the NSCLC sub-segment, patients with specific genetic markers are emerging as prime beneficiaries, thanks to targeted therapy advancements. Research and development investments are critical in propelling the market forward, with a focus on improving TIL harvesting techniques and enhancing cell expansion processes. As regulatory landscapes evolve, streamlined approval pathways are expected to accelerate market growth, fostering innovation and expanding therapeutic options.

Market Segmentation
TypeAutologous TIL Therapy, Allogeneic TIL Therapy
ProductCell Culture Media, Reagents and Kits, Instruments, Software
ServicesManufacturing, Quality Control, Consulting, Logistics
TechnologyGenetic Engineering, Cell Expansion, Cryopreservation, Bioreactors
ApplicationOncology, Hematology, Solid Tumors, Rare Diseases
End UserHospitals, Specialty Clinics, Research Institutes, Biopharmaceutical Companies
ProcessIsolation, Expansion, Activation, Infusion
StagePreclinical, Clinical, Commercial
SolutionsTurnkey Solutions, Custom Solutions, Integrated Solutions

Market Snapshot:

The TIL Therapy Market is witnessing a dynamic landscape, characterized by evolving market shares and strategic pricing models. New product launches are invigorating the market, driven by advancements in immunotherapy technologies. Companies are focusing on innovative treatments that enhance patient outcomes. This competitive environment encourages firms to differentiate through unique offerings and strategic collaborations. Pricing strategies are increasingly influenced by value-based models, reflecting the emphasis on cost-effectiveness and patient-centric care. The competitive landscape of the TIL Therapy Market is marked by intense rivalry among key players. Companies are engaging in benchmarking to maintain a competitive edge, leveraging technological innovations and strategic partnerships. Regulatory frameworks significantly influence market dynamics, with stringent guidelines shaping product development and approval processes. The regulatory landscape in North America and Europe is particularly impactful, dictating market entry and expansion strategies. As the market evolves, regulatory compliance and strategic agility remain crucial for sustained growth and competitiveness.

Geographical Overview:

The TIL Therapy market is witnessing a notable expansion across various regions, each presenting unique growth opportunities. North America currently leads the market, propelled by robust investments in biotechnology and advanced cancer treatment modalities. The presence of leading biotech firms and research institutions further bolsters the region's dominance. Europe follows closely, driven by significant research funding and a strong emphasis on innovative cancer therapies. The region's regulatory support for novel treatments enhances its market prospects. In Asia Pacific, the market is rapidly growing, supported by increasing healthcare expenditure and advancements in medical research. Countries like China and India are emerging as key players due to their expanding biotech sectors and supportive government policies. Latin America and the Middle East & Africa are also showing promising growth potential. In Latin America, rising healthcare investments are fostering market expansion, while in the Middle East & Africa, increasing awareness and adoption of advanced therapies are driving market growth.

Key Trends and Drivers:

The TIL Therapy Market is experiencing robust growth, propelled by advancements in personalized medicine and immunotherapy. These therapies are gaining traction due to their potential to target specific cancer cells, minimizing damage to healthy tissues. Researchers are focusing on enhancing TIL therapy efficacy, leveraging genetic engineering and combination therapies. Additionally, increased investment in biotechnology and cancer research is driving market expansion. Governments and private entities are funding initiatives to develop innovative cancer treatments. This financial support is accelerating clinical trials and regulatory approvals, thereby boosting market dynamics. Rising cancer prevalence globally is also a significant market driver. Patients and healthcare providers are increasingly adopting TIL therapies due to their promising clinical outcomes. The trend towards precision medicine is further augmenting market growth. Opportunities are emerging in developing regions where healthcare infrastructure is improving. Companies investing in R&D and strategic collaborations are well-positioned to capture market share. The TIL Therapy Market is poised for continued expansion as demand for effective cancer treatments rises.

Restraints and Challenges:

The TIL Therapy Market encounters several significant restraints and challenges. A predominant challenge is the high cost of manufacturing and development. This financial burden limits accessibility and scalability, particularly in emerging markets. Additionally, regulatory hurdles and lengthy approval processes can delay the introduction of new therapies, stifling innovation and market penetration. Another concern is the complex logistics of TIL therapy, which require specialized facilities and skilled personnel. This complexity can increase operational costs and limit widespread adoption. Furthermore, there is a scarcity of comprehensive clinical data supporting the long-term efficacy and safety of TIL therapies, which can deter investment and patient acceptance. The market also grapples with intense competition from alternative immunotherapies, such as CAR-T and checkpoint inhibitors, which can overshadow TIL therapies. Lastly, patient recruitment for clinical trials remains a challenge, often due to stringent eligibility criteria, affecting the speed and success of research initiatives.

Key Players:

Iovance Biotherapeutics, Adaptimmune Therapeutics, Kite Pharma, Immunocore, Turnstone Biologics, Tmunity Therapeutics, Cellectis, Autolus Therapeutics, Fate Therapeutics, Atara Biotherapeutics, Neogene Therapeutics, Instil Bio, Marker Therapeutics, Gritstone Oncology, Ziopharm Oncology

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: TIL Therapy Market Overview

  • 1.1 Objectives of the Study
  • 1.2 TIL Therapy Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Stage
  • 2.11 Key Highlights of the Market, by Solutions
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Stage
  • 3.10 Market Attractiveness Analysis, by Solutions
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: TIL Therapy Market Outlook

  • 4.1 TIL Therapy Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: TIL Therapy Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: TIL Therapy Market Size

  • 6.1 TIL Therapy Market Size, by Value
  • 6.2 TIL Therapy Market Size, by Volume

7: TIL Therapy Market, by Type

  • 7.1 Market Overview
  • 7.2 Autologous TIL Therapy
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Allogeneic TIL Therapy
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: TIL Therapy Market, by Product

  • 8.1 Market Overview
  • 8.2 Cell Culture Media
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Reagents and Kits
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Instruments
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Software
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: TIL Therapy Market, by Services

  • 9.1 Market Overview
  • 9.2 Manufacturing
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Quality Control
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Consulting
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Logistics
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: TIL Therapy Market, by Technology

  • 10.1 Market Overview
  • 10.2 Genetic Engineering
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Cell Expansion
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Cryopreservation
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Bioreactors
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: TIL Therapy Market, by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Hematology
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Solid Tumors
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Rare Diseases
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: TIL Therapy Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Specialty Clinics
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Biopharmaceutical Companies
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: TIL Therapy Market, by Process

  • 13.1 Market Overview
  • 13.2 Isolation
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Expansion
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Activation
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Infusion
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: TIL Therapy Market, by Stage

  • 14.1 Market Overview
  • 14.2 Preclinical
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Clinical
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Commercial
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: TIL Therapy Market, by Solutions

  • 15.1 Market Overview
  • 15.2 Turnkey Solutions
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Custom Solutions
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Integrated Solutions
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: TIL Therapy Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by End User
    • 16.2.8 North America Market Size and Forecast, by Process
    • 16.2.9 North America Market Size and Forecast, by Stage
    • 16.2.10 North America Market Size and Forecast, by Solutions
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by End User
      • 16.2.9.7 United States Market Size and Forecast, by Process
      • 16.2.9.8 United States Market Size and Forecast, by Stage
      • 16.2.9.9 United States Market Size and Forecast, by Solutions
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by End User
      • 16.2.10.7 Canada Market Size and Forecast, by Process
      • 16.2.10.8 Canada Market Size and Forecast, by Stage
      • 16.2.10.9 Canada Market Size and Forecast, by Solutions
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by End User
    • 16.3.8 Europe Market Size and Forecast, by Process
    • 16.3.9 Europe Market Size and Forecast, by Stage
    • 16.3.10 Europe Market Size and Forecast, by Solutions
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Solutions
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by End User
      • 16.3.10.7 Germany Market Size and Forecast, by Process
      • 16.3.10.8 Germany Market Size and Forecast, by Stage
      • 16.3.10.9 Germany Market Size and Forecast, by Solutions
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by End User
      • 16.3.11.7 France Market Size and Forecast, by Process
      • 16.3.11.8 France Market Size and Forecast, by Stage
      • 16.3.11.9 France Market Size and Forecast, by Solutions
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by End User
      • 16.3.12.7 Spain Market Size and Forecast, by Process
      • 16.3.12.8 Spain Market Size and Forecast, by Stage
      • 16.3.12.9 Spain Market Size and Forecast, by Solutions
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by End User
      • 16.3.13.7 Italy Market Size and Forecast, by Process
      • 16.3.13.8 Italy Market Size and Forecast, by Stage
      • 16.3.13.9 Italy Market Size and Forecast, by Solutions
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by End User
      • 16.3.14.7 Netherlands Market Size and Forecast, by Process
      • 16.3.14.8 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.9 Netherlands Market Size and Forecast, by Solutions
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by End User
      • 16.3.15.7 Sweden Market Size and Forecast, by Process
      • 16.3.15.8 Sweden Market Size and Forecast, by Stage
      • 16.3.15.9 Sweden Market Size and Forecast, by Solutions
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by End User
      • 16.3.16.7 Switzerland Market Size and Forecast, by Process
      • 16.3.16.8 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.9 Switzerland Market Size and Forecast, by Solutions
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by End User
      • 16.3.17.7 Denmark Market Size and Forecast, by Process
      • 16.3.17.8 Denmark Market Size and Forecast, by Stage
      • 16.3.17.9 Denmark Market Size and Forecast, by Solutions
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by End User
      • 16.3.18.7 Finland Market Size and Forecast, by Process
      • 16.3.18.8 Finland Market Size and Forecast, by Stage
      • 16.3.18.9 Finland Market Size and Forecast, by Solutions
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by End User
      • 16.3.19.7 Russia Market Size and Forecast, by Process
      • 16.3.19.8 Russia Market Size and Forecast, by Stage
      • 16.3.19.9 Russia Market Size and Forecast, by Solutions
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Solutions
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Solutions
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by End User
      • 16.4.9.7 China Market Size and Forecast, by Process
      • 16.4.9.8 China Market Size and Forecast, by Stage
      • 16.4.9.9 China Market Size and Forecast, by Solutions
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by End User
      • 16.4.10.7 India Market Size and Forecast, by Process
      • 16.4.10.8 India Market Size and Forecast, by Stage
      • 16.4.10.9 India Market Size and Forecast, by Solutions
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by End User
      • 16.4.11.7 Japan Market Size and Forecast, by Process
      • 16.4.11.8 Japan Market Size and Forecast, by Stage
      • 16.4.11.9 Japan Market Size and Forecast, by Solutions
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by End User
      • 16.4.12.7 South Korea Market Size and Forecast, by Process
      • 16.4.12.8 South Korea Market Size and Forecast, by Stage
      • 16.4.12.9 South Korea Market Size and Forecast, by Solutions
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by End User
      • 16.4.13.7 Australia Market Size and Forecast, by Process
      • 16.4.13.8 Australia Market Size and Forecast, by Stage
      • 16.4.13.9 Australia Market Size and Forecast, by Solutions
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by End User
      • 16.4.14.7 Singapore Market Size and Forecast, by Process
      • 16.4.14.8 Singapore Market Size and Forecast, by Stage
      • 16.4.14.9 Singapore Market Size and Forecast, by Solutions
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by End User
      • 16.4.15.7 Indonesia Market Size and Forecast, by Process
      • 16.4.15.8 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.9 Indonesia Market Size and Forecast, by Solutions
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by End User
      • 16.4.16.7 Taiwan Market Size and Forecast, by Process
      • 16.4.16.8 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.9 Taiwan Market Size and Forecast, by Solutions
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by End User
      • 16.4.17.7 Malaysia Market Size and Forecast, by Process
      • 16.4.17.8 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.9 Malaysia Market Size and Forecast, by Solutions
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by End User
    • 16.5.8 Latin America Market Size and Forecast, by Process
    • 16.5.9 Latin America Market Size and Forecast, by Stage
    • 16.5.10 Latin America Market Size and Forecast, by Solutions
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by End User
      • 16.5.9.7 Brazil Market Size and Forecast, by Process
      • 16.5.9.8 Brazil Market Size and Forecast, by Stage
      • 16.5.9.9 Brazil Market Size and Forecast, by Solutions
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by End User
      • 16.5.10.7 Mexico Market Size and Forecast, by Process
      • 16.5.10.8 Mexico Market Size and Forecast, by Stage
      • 16.5.10.9 Mexico Market Size and Forecast, by Solutions
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by End User
      • 16.5.11.7 Argentina Market Size and Forecast, by Process
      • 16.5.11.8 Argentina Market Size and Forecast, by Stage
      • 16.5.11.9 Argentina Market Size and Forecast, by Solutions
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Solutions
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Solutions
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Solutions
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by End User
      • 16.6.10.7 UAE Market Size and Forecast, by Process
      • 16.6.10.8 UAE Market Size and Forecast, by Stage
      • 16.6.10.9 UAE Market Size and Forecast, by Solutions
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by End User
      • 16.6.11.7 South Africa Market Size and Forecast, by Process
      • 16.6.11.8 South Africa Market Size and Forecast, by Stage
      • 16.6.11.9 South Africa Market Size and Forecast, by Solutions
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Solutions
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Iovance Biotherapeutics
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Adaptimmune Therapeutics
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Kite Pharma
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Immunocore
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Turnstone Biologics
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Tmunity Therapeutics
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Cellectis
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Autolus Therapeutics
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Fate Therapeutics
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Atara Biotherapeutics
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Neogene Therapeutics
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Instil Bio
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Marker Therapeutics
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Gritstone Oncology
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Ziopharm Oncology
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis